| 2025年年报 | 2025年三季报 | 2025年中报 | 2024年年报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 临床合理用药系统(元) | 181,490,178.71 | 132,799,239.73 | 88,608,508.43 | 181,414,554.14 |
| 软件开发和技术服务(元) | 4,400,334.06 | 1,761,273.44 | 1,282,777.67 | 4,147,972.58 |
| 数据更新和运维服务(元) | 65,165,002.41 | 47,285,539.75 | 31,203,012.00 | 59,780,491.59 |
| 营业成本(元) | ||||
| 临床合理用药系统(元) | 23,736,714.14 | 17,495,101.79 | 11,247,378.95 | 21,410,127.64 |
| 软件开发和技术服务(元) | 3,943,428.44 | 1,705,320.08 | 1,268,394.60 | 4,090,232.38 |
| 数据更新和运维服务(元) | 25,807,230.88 | 18,744,100.68 | 12,033,714.33 | 24,483,103.48 |
| 毛利(元) | ||||
| 临床合理用药系统(元) | 157,753,464.57 | 115,304,137.94 | 77,361,129.48 | 160,004,426.50 |
| 软件开发和技术服务(元) | 456,905.62 | 55,953.36 | 14,383.07 | 57,740.20 |
| 数据更新和运维服务(元) | 39,357,771.53 | 28,541,439.07 | 19,169,297.67 | 35,297,388.11 |
| 毛利率(%) | ||||
| 临床合理用药系统(%) | 86.92 | 86.83 | 87.31 | 88.20 |
| 软件开发和技术服务(%) | 10.38 | 3.18 | 1.12 | 1.39 |
| 数据更新和运维服务(%) | 60.40 | 60.36 | 61.43 | 59.04 |
| 收入构成(%) | ||||
| 临床合理用药系统(%) | 72.29 | 73.03 | 73.17 | 73.94 |
| 软件开发和技术服务(%) | 1.75 | 0.97 | 1.06 | 1.69 |
| 数据更新和运维服务(%) | 25.96 | 26.00 | 25.77 | 24.37 |
| 毛利构成(%) | ||||
| 临床合理用药系统(%) | 79.85 | 80.13 | 80.13 | 81.90 |
| 软件开发和技术服务(%) | 0.23 | 0.04 | 0.01 | 0.03 |
| 数据更新和运维服务(%) | 19.92 | 19.83 | 19.86 | 18.07 |